1L Nsclc DX All Comer Non Squamous
Research payments
$2,913,749
Through program year 2022, $2,913,749 in research payments was reported against 1L Nsclc DX All Comer Non Squamous, across 841 payments.
- Paid by (largest first)
- F. Hoffmann-La Roche AG; Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $8,500 | 2 |
| 2021 | Research | $677,999 | 127 |
| 2020 | Research | $977,228 | 363 |
| 2019 | Research | $1,250,023 | 349 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Neil Belman Fountain Hill, PA Named on 47 payments
- Shamudheen Mohammed Rafiyath Tucson, AZ Named on 46 payments
- Mohammad Al-Nsour Toledo, OH Named on 35 payments
- Mohit Narang Columbia, MD Named on 29 payments
- Saji Eapen Knoxville, TN Named on 24 payments
- Robert Jotte Lone Tree, CO Named on 22 payments
- Dylan Zylla Minneapolis, MN Named on 22 payments
- William Martin Bend, OR Named on 22 payments
- Gene Finley Natrona Heights, PA Named on 21 payments
- Haiying Cheng Bronx, NY Named on 21 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.